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Abstract
Background: Because abdominal obesity is predisposed to various metabolic disorders, it is of major importance
to assess and track the changes with time of this specific fat mass. The main issue for clinicians or researchers is to
use techniques for assessing abdominal fat deposition and its accumulation or changes over time, without
sacrificing of experimental subjects. In the rat, techniques to investigate in-vivo visceral fat mass are lacking. The
purpose of the study was to validate indirect Dual-energy X-ray Absorptiometry technique and abdominal
circumference measurement as tools to predict visceral adipose tissue in rats.
Forty-three Wistar male rats from different body weight, fat mass and ages were included in the study. Visceral fat
mass was assessed by weighing the total perirenal and peri-epididymal adipose tissues after dissection. Statistical
methods were used to discriminate the best region of interest allowing the in-vivo measure of Central Fat Mass by
DXA. Abdominal circumference was measured at the same time as the DXA scan.
Results: A region of interest including Central Fat Mass from the whole body DXA scan (extending from L2 to L5
vertebrae), correlated strongly with ex-vivo Fat Mass (r = 0.94, p < 0.001). Abdominal circumference correlated
significantly with ex-vivo Fat Mass (r = 0.82, p < 0.001) and Central Fat Mass (0.90, p < 0.001) in the whole group of
rats. When dividing the whole group into lean and fat rats, correlations remained significant between Central Fat
Mass and ex-vivo Fat Mass but disappeared for the lean group between abdominal circumference and ex-vivo Fat
Mass.
Conclusions: This study validates the Central Fat Mass determined by DXA as a non-sacrificial technique to assess
visceral fat for in-vivo investigations in rats. The abdominal circumference measure appears useful in studying
overweight or obese rats. These two techniques could be convenient tools in follow-up and longitudinal studies.
Background
Ageing, characterized by an increase of lipid consump-
tion and sedentary lifestyle is known to be linked with
metabolic pathologies. The excess of lipid provided by
food is stored in localized sites (abdomen, liver, hips)
and becomes pathological, disturbing a great number of
metabolic functions and contributing to the rise in
metabolic syndrome [1]. Abdominal obesity is also
strongly linked with diabetes mellitus and an increase of
cardiovascular disease, resulting in a prevalence of
adverse cardiovascular events [2,3].
The mechanisms leading to the local accumulation of
adipose tissue are not fully elucidated in both humans
and animals. Therefore, the main issue for clinicians or
researchers is to have techniques for assessing the
abdominal fat deposition and its accumulation or
change over time. Moreover, the sacrifice of experimen-
tal animals permits the determination of the exact value
of visceral fat tissue but prohibits follow up of the
change to this tissue in vivo.
Studies on the accumulation of abdominal fat mass in
animals could help to better understand the mechanisms
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of investigation are lacking.
In rodents, the total body weight measure does not
give relevant information about body composition,
which is an essential parameter in this kind of investiga-
tion. On the other hand, waist circumference measures
have been shown to significantly correlate with cardio-
vascular disease in humans [4]. Among several anthro-
pometric measurements, waist circumference was also
found to be the best predictor of intra-abdominal fat
thickness in normal subjects and therefore of central
obesity [5]. While the ability to predict visceral fat from
circumferences and diameters in obese humans has
been validated [6], no anthropometric technique has
been developed in animals to date. As aforementioned,
the accumulation of intra-abdominal fat can be mea-
sured by direct weighing of fat after dissection. Some
studies weighed intra-abdominal visceral fat including
retroperitoneal, epididymal, and mesenteric fat tissues
[7-11]. Lac et al. [12] measured visceral fat mass by
weighing the left perirenal fat pad alone, considering
that it was representative of whole abdominal fat tissue.
However, because of the sacrifice involved by such tech-
niques, longitudinal studies are excluded. The use of
computed tomography in assessing body composition
has been shown to be an useful technique to quantify
fat tissue deposits [7]. Magnetic resonance imaging has
also been used to measure abdominal fat, and discrimi-
nate between locations of adipose tissue [13]. Unfortu-
nately, these two techniques are hampered by
availability and cost; resulting in infrequent use in longi-
tudinal studies. Thus, no technique is currently available
to estimate in vivo abdominal fat mass in animals.
Due to its excellent reproducibility [14], Dual-energy X-
ray absorptiometry (DXA) has become one of the best
technique for assessing body composition in humans [15]
and rodents [16]. The DXA analysis software allows spe-
cific regions to be identified making it an expedient and
cost-effective method to estimate abdominal adipose tis-
sue in humans [17,18]. The validity and reliability of
DXA to measure adiposity in the abdominal region has
been determined in humans [19]. Kamel et al. [20]
showed that central fat mass determined by this techni-
que was strongly associated with the value of abdominal
visceral fat in both men and women, but no study has
investigated abdominal fat mass in rats. Similarly, abdom-
inal circumference measures are among established cri-
teria for human metabolic syndrome diagnosis, yet no
anthropometric technique has been developed in animals.
Therefore, the purpose of the present study was to
validate a DXA technique and abdominal circumference
measurement as predictors of visceral adipose tissue in
lean and fat male rats.
Methods
Animal Care
All experimental designs and procedures were made in
accordance to the current legislation on animal experi-
ence in France and were approved by the ethical com-
mittee for animal experimentation (CREEA Auvergne,
CE1-09). Considering a minimum of 10% difference of
visceral fat mass between fat and lean rats, the statistical
power calculation resulted in a number of 12 rats per
groups for p < 0.05 and a type II error of 0.01%. There-
fore, we included groups of 14 rats.
Forty-three Wistar male rats (CERJ Janvier®, Le Gen-
est Saint-Isle, France) were included in the study. In
order to measure a large range of subjects, we chose a
group of 29 rats aged 11 months and 14 rats aged
7 months with a range of body weights. Among the
group of 29 rats, 14 rats were previously fed with a
normal diet (lean group) and 15 rats were given a high
f a t / h i g hs u c r o s ed i e t( f a tg r o u p )f o rf o u rm o n t h st o
increase fat mass storage. The 7-month old rats were
fed with a normal diet. Rats were individually housed
in a temperature-controlled room (20-22°C) and a
reversed light-dark cycle (light on 20h00-08h00) was
maintained. The rats had free access to water. All mea-
sures were performed in the early morning to avoid
diurnal complications.
Total Body Composition by DXA
A Hologic QDR 4500 device was used with an internal
adapted collimator for small animal measurements
(Hologic QDR Software for Windows XP version, Copy-
right
© 1986-2002 Hologic Inc.). Rat whole body mea-
surement required 240 seconds and provided global and
regional body composition results. The scan field was
adjustable to a maximum of 36 cm (L) * 18 cm (W).
Spatial resolution was approximately 1 mm. A special
designed small animal step phantom was scanned daily
to calibrate the body composition results. Rats were
anaesthetized before measurements. Anesthesia con-
sisted on an intra-peritoneal injection of a solution of
Acepromazine Vetranquil® (0.5 ml.kg
-1 of body weight)
and Ketamine Imalgène® (0.75 ml.kg
-1 of body weight).
After anesthesia, rats were positioned ventrally on a
reference film to reproduce the position illustrated in
figure 1.
One week before sacrifice, body mass, fat mass and
lean mass of all animals were assessed by DXA using
specific small animal body composition software (line
spacing: 0.254 mm, resolution: 0.127 mm). The coeffi-
cients of variation (CV’s) were determined for these
parameters from six repeated measurements with repo-
sitioning on eight animals. The CV’s were 4.79%, and
0.19 % for fat mass, and body mass, respectively.
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Rats were fasted for 12 hours before sacrifice. They were
euthanized by decapitation under isoflurane anesthesia.
Visceral fat mass was assessed by weighing the total
perirenal and peri-epididymal adipose tissues. The
weights of these two tissues were combined to form the
ex-vivo Fat Mass.
Central fat mass (CFM) Area Determination
The area determination was performed in a group of
28 rats including 14 rats aged of 7 months and the fat
group (n = 14, 11 months old). In order to select the
more accurate method for assessing abdominal fat mass
by DXA, four regions of interest (ROI) extracted from
the whole body scan were tested (figures 2A, B, C and
2D). These ROIs were defined after enlarging the total
spine. They consisted of rectangular boxes extending
vertically from one vertebral space to another and the
lateral borders extending to the edge of the abdominal
soft tissue. All trunk tissues, including intra abdominal
fat and peripheral subcutaneous fat within these stan-
dardized height regions were selected for analysis. From
these ROIs, we selected the region displaying the best
correlation with ex-vivo F a tM a s s .W ec a l l e dt h ef a t
mass measured within the chosen region “Central Fat
Mass” (CFM) in order to distinguish it from the ana-
tomic visceral fat. All investigations were performed by
the same technician in order to avoid any bias linked to
the inter-operator error.
Abdominal Circumference (AC)
The abdominal circumference was performed in a group
of 29 rats including the group of lean rats (n = 15) and
the group of fat rats (n = 14) Before each DXA mea-
sures, abdominal circumference (AC) was assessed on
the largest zone of the rat abdomen using a plastic non
extensible measuring tape (Rollfix, Hoechstmass®, Ger-
many) with an accuracy of 0.1 cm. Rats were placed in
ventral position.
Statistical Analysis
The Gaussian distribution for each parameter was
assessed by a Shapiro-Wilk test. In case of non-normal
distribution, the data were log-transformed for analyses.
In order to assess the potential relationships between
the variables, we performed a correlation matrix
between fat mass from each DXA ROI and ex-vivo Fat
Mass. The CV for AC measures was determined follow-
ing three analyses on 13 rats. The same operator reposi-
tioned the measuring tape three times. For assessing the
CV of CFM, the ROI was repositioned two times on
twelve scans by the same operator. Correlation matrix
was generated for AC, ex-vivo Fat Mass and CFM. In
case of significant correlation, linear regressions were
Figure 1 Ventral position of rats on DXA.
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Characteristics differences between lean and fat rats
were tested using unpaired t-tests. A correlation matrix
between AC, ex-vivo Fat Mass and CFM distinguishing
fat and lean groups was compiled. A paired Student
t-test was used to compare ex-vivo Fat Mass and CFM
for the whole population. A 2 × 2 ANOVA allowed
comparing the differences between lean and fat groups,
and the ex-vivo Fat Mass and CFM values. Analysis was
carried out using SPSS Advanced Statistics software ver-
sion 17 (SPSS Inc., Chicago, IL) and data are presented
as mean ± SD.
Results
The characteristics of the rats involved in the CFM
determination are presented table 1. Table 2 shows the
correlation matrix between the four different ROIs and
ex-vivo Fat Mass. All ROIs were significantly correlated
with ex-vivo Fat Mass (p < 0.001) The ROI with the
strongest correlation (r = 0.94, p < 0.001) was the ROI
e x t e n d i n gf r o mL 2t oL 5v e r t e b r a e( F M _ L 2 _ L 5 ) .T h i s
ROI was subsequently selected to represent the CFM.
Using this ROI, the coefficient of variation calculated for
CFM was 1.2%. Figure 3 displays the linear regression
between CFM and ex-vivo Fat Mass. The explained var-
iance for this relationship (R² = 0.88, p < 0.0001), high-
lights the very strong association between these data.
The characteristics of lean, fat and the whole group
rats are presented in table 3. As expected, the character-
istics of fat rats were significantly larger than those of
Figure 2 Print-out of Dual-x-Ray Absorptiometry (DXA) scan, showing regions of interest (ROI). (A) ROI extending from L1 to L6
vertebrae. Fat mass from this ROI was called FM_L1_L6. (B) ROI extending from L1 to S3 vertebrae. Fat mass from this ROI was called FM_L1_S3
(C) ROI extending from L2 to L5 vertebrae. Fat mass from this ROI was called FM_L2_L5 (D) ROI extending from L3 to S3 vertebrae. Fat mass
from this ROI was called FM_L3_S3.
Table 1 Characteristics of the rats
Mean SD Min Max
Age (months) 9 2 7 11
Total body weight (g) 612,62 130,08 445,09 902,47
Total body Fat (g) 171,02 90,44 63,11 393,84
P Fat (%) 26,29 8,98 11,63 43,64
ex-vivo Fat Mass (g) 39,9 22,45 10,43 77,5
n=2 8
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Fat Mass in the whole group as well as in fat and lean
groups (p < 0.005). The CV for AC was 2.6 %. The cor-
relation matrix between AC, CFM and ex-vivo Fat Mass
for the total population (fat and lean rats) is displayed
table 4. Within the whole population, AC correlated
positively with both CFM (r = 0.90, p < 0.001) and
ex-vivo Fat Mass (r = 0.82, p < 0.001). The slope of
regression between AC and CFM (Figure 4A) displayed
a strong association (R² = 0.82, p < 0.0001). Figure 4B
shows a strong relationship between AC and ex-vivo Fat
Mass (R² = 0.68, p < 0.0001). The correlation matrix
b e t w e e nA C ,C F M ,a n dex-vivo Fat Mass for fat and
lean rats is displayed table 5. Correlation between CFM
and ex-vivo Fat Mass remained significant in the two
subgroups of rats (r = 0.60, p < 0.05 for lean rats and r
= 0.734, p < 0.01 for fat rats) When considering the
lean rats alone, the correlation between AC and both
CFM (r = 0.51) and ex-vivo Fat Mass (r = 0.43) failed to
reach significance. Nevertheless, for fat rats, AC corre-
lated strongly with CFM (r = 0.93, p < 0.001) and the
coefficient of correlation between AC and ex-vivo Fat
Mass was weaker than for the whole population but
remained significant (r = 0.583, p = 0.029).
Discussion
The main result of the present study demonstrated the
ability to perform an indirect determination of the visc-
eral fat mass in rats, using the technique of DXA. In
addition, this study showed that fat mass could be accu-
rately assessed by an anthropometric technique in fat
rats.
The first objective was to establish the DXA region of
interest (ROI) from the whole body scan in order to
determine the fat mass demonstrating the best correla-
tion with ex-vivo Fat Mass obtained by weighing. In
human studies, landmarks based upon the intervertebral
spaces are used to determine abdominal fat [17,18]. The
Table 2 Correlation matrix for Fat Mass from the DXA ROI’s and ex-vivo Fat Mass
FM_L1_L6 (g) FM_L1_S3 (g) FM_L2_L5 (g) FM_L3_S3 (g) ex-vivo Fat Mass (g)
Pearson Sig. Pearson Sig. Pearson Sig. Pearson Sig. Pearson Sig.
FM_L1_L6 (g) 1,00
FM_L1_S1 (g) 0,808** 0,001 1,00
FM_L2_L5 (g) 0,850** 0,001 0,954** 0,001 1,00
FM_L3_S3 (g) 0,823** 0,001 0,971** 0,001 0,983** 0,001 1,00
ex-vivo Fat Mass (g) 0,835** 0,001 0,933** 0,001 0,940** 0,001 0,928** 0,001 1,00 0,001
n = 28; ** p < 0.01
Figure 3 Linear regression between CFM and ex-vivo Fat Mass. CFM = Central Fat Mass; n = 28.
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marks in rats. Therefore, we decided to form ROIs as
rectangular boxes extending vertically from one inter-
vertebral space to another. The ROI determined in our
study (FM_L2_L5) was quite similar to the ROI used in
humans, extending from L2 to L4 vertebrae [18].
The ROI chosen includes only a small part of peri-
epydidimal adipose tissue. Indeed, the localization of
this adipose tissue is lower in the abdomen. Neverthe-
less, correlations between the different ROIs and only
perirenal or peri-epididymal adipose tissues were tested
but coefficients of correlation were lower than if the two
adipose tissues were combined.
Different studies [7-12] have weighed visceral fat after
dissection, but no real consensus has been established to
identify which fat deposit among retroperitoneal, epidi-
dymal, peri-renal and mesenteric fat tissues is more
representative of visceral fat mass. In rats, dissection of
mesenteric and subcutaneous fat is difficult and some
errors due to dissection might occur. In contrast,
removing perirenal and peri-epididymal adipose appears
to constitute a reliable technique. Therefore we com-
bined these two adipose tissues to form ex-vivo Fat
Mass.
The strong correlation observed between CFM
assessed by DXA and ex-vivo Fat Mass demonstrates
that CFM could be a useful predictor of visceral fat
mass in rats. In humans, similar results have already
been observed in obese or non obese women when
comparing Intra-Abdominal Fat by Magnetic Resonance
Imaging and Total Fat or CFM by DXA [18,21]. In the
present study, the specific analyses of these relationships
were conducted in subgroups of lean and fat rats. The
correlations between CFM and ex-vivo Fat Mass
remained positive in each group, although blunted in
the lean rats.
However, as DXA measures of CFM, includes abdom-
inal fat plus peripheral subcutaneous fat, DXA values
were higher than ex-vivo Fat Mass because it includes
only the total perirenal and peri-epididymal adipose tis-
sues. Thus, the higher values found with the DXA
method can be explained by subcutaneous fat which is
excluded in ex-vivo Fat Mass. Indeed, DXA cannot dis-
tinguish between intra-abdominal and subcutaneous fat
in humans and animals [22]. Despite a small over-esti-
mation of DXA, the strong correlation observed
between CFM and ex-vivo Fat Mass showed that DXA
could be a useful predictor of ex-vivo visceral fat mass
in rats.
The second objective was to validate the AC measure
as an anthropometric method for assessing visceral fat
mass. Within the whole population of rats, a strong sig-
nificant correlation was observed between AC values
and both CFM by DXA and ex-vivo Fat Mass. These
results showed that AC could be a useful tool to predict
visceral fat mass. When dividing the whole population
into fat and lean rats, we observed the relationships
between AC, CFM and ex-vivo Fat Mass were main-
tained for the fat rats but correlations with the lean rats
disappeared. The small sample of subjects resulting
from the division of the whole group may affect the sta-
tistical power of relationships between variables. Despite
the sample effect, these results underline the fact that
when animals are not characterized by obesity, AC is no
longer relevant to assess abdominal fat. These results
revealed that AC is a good indicator for predicting visc-
eral fat mass in case of obesity. To date, no other study
Table 3 Characteristics of the total, fat and lean groups of rats
total n = 29 lean n = 15 fat n = 14
Mean ± SD Range Mean ± SD Range Mean ± SD Range p
a
Age (months) 11 11-11 11 11-11 11 11-11 NS
Total body weight (g) 676,63 ± 82,35 521,86-902,47 627,06 ± 62,80 521,86-744,44 729,73 ± 647,64 647,64-902,47 0.001
Total body Fat (g) 202,03 ± 66,80 103,96-393,84 159,01 ± 39,16 103,96-248,47 248,12 ± 59,47 1170,75-393,84 0.001
P Fat (%) 29,36 ± 6,83 19,30-43,64 25,33 ± 5,52 19,30-35,63 33,68 ± 5,38 24,76-43,64 0.001
ex-vivo Fat Mass (g) 43,87 ± 18,40 19,35-77,5 28,86 ± 6,41 19,35-40,47 59,96 ± 12,08 59,96-12,08 0.001
CFM (g) 48,88 ± 19,44
b 21,2-99,2 34,63 ± 9,32
b 21,2-57,5 64,14 ± 15,35
b 41,9-92,2 0.001
AC (cm) 24,90 ± 2,04
(SE = 0.38)
22-29 23,43 ± 1,29 (SE = 0.33) 22-26 26,46 ± 1,42 (SE = 0.38) 24-29 0.001
CFM = Central Fat Mass; AC = Abdominal circumference; SE = Standard Error;
a Comparison by unpaired t-test between fat rats (n = 14) and lean rats (n = 15);
b
CMF significantly different of ex-vivo Fat Mass (paired t-test. p < 0.05); n = 29
Table 4 Correlation matrix for Abdominal Circumference,
CFM and ex-vivo Fat Mass in total population
CFM (g) AC (cm) ex-vivo Fat
Mass (g)
Pearson Sig. Pearson Sig. Pearson Sig.
CFM (g) 1
AC (cm) 0,899** 0,001 1
ex-vivo Fat Mass (g) 0,890** 0,001 0,822** 0,001 1 0,001
**p < 0.01 CFM = Central Fat Mass; AC = Abdominal circumference n = 29
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Nevertheless, different studies conducted in human sub-
jects concluded that waist circumference is the best
anthropometric predictor of intra abdominal fat thick-
ness [5,17,18]. Similarly, the present study has shown
that the AC measure could be a useful anthropometric
technique for assessing in-vivo abdominal fat mass sto-
rage in fat rats.
Conclusions
Both AC and CFM by DXA were good indicators for
measuring abdominal fat mass storage. Coefficients of
A 
B
Figure 4 Linear regressions for Abdominal Circumference. (A) Linear regression between Abdominal Circumference and CMF by DXA. CFM =
Central Fat Mass; AC = Abdominal Circumference; n = 29. (B) Linear regression between Abdominal Circumference and ex-vivo Fat Mass. AC =
Abdominal Circumference; n = 29.
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CFM and AC, respectively. These values highlight the
fact that these two measures can be used with precision
and reliability. DXA and AC measures can be consid-
ered as non-invasive alternative techniques in determin-
ing visceral fat mass in rodents. These techniques have
the potential to reduce the cost and number of rats
required when using traditional sacrificial protocols.
Moreover, abdominal circumference like other anthro-
pometric measurements is inexpensive, quick and easy
to perform. The most important outcome of the present
study was that these two techniques can be used for in-
vivo investigations, thereby allowing follow-up and long-
itudinal studies.
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CFM = Central Fat Mass; AC = Abdominal Circumference; **p < 0.01; *p < 0.05; NS = not statistically significant; n = 29
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